Birdwatch Archive

Birdwatch Note

2023-03-20 03:37:59 UTC - NOT_MISLEADING

There are nearly 100 studies which show positive evidence of Ivermectin use against various stages of covid. This is a hotly contested debate. This tweet is a matter of opinion. This note is best served in comment to the tweet. https://c19ivm.org/meta.html

Written by 7DD77FA934335AB7B4B777A968A8D56D68AA32E160053176586008F224AD5B99
Participant Details

Original Tweet

Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1637425221324926976

Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.

All Information

  • ID - 1637659725994262528
  • noteId - 1637659725994262528
  • participantId -
  • noteAuthorParticipantId - 7DD77FA934335AB7B4B777A968A8D56D68AA32E160053176586008F224AD5B99 Participant Details
  • createdAtMillis - 1679283479581
  • tweetId - 1637425221324926976
  • classification - NOT_MISLEADING
  • believable -
  • harmful -
  • validationDifficulty -
  • misleadingOther - 0
  • misleadingFactualError - 0
  • misleadingManipulatedMedia - 0
  • misleadingOutdatedInformation - 0
  • misleadingMissingImportantContext - 0
  • misleadingUnverifiedClaimAsFact - 0
  • misleadingSatire - 0
  • notMisleadingOther - 0
  • notMisleadingFactuallyCorrect - 0
  • notMisleadingOutdatedButNotWhenWritten - 0
  • notMisleadingClearlySatire - 0
  • notMisleadingPersonalOpinion - 1
  • trustworthySources - 1
  • summary
    • There are nearly 100 studies which show positive evidence of Ivermectin use against various stages of covid. This is a hotly contested debate. This tweet is a matter of opinion. This note is best served in comment to the tweet. https://c19ivm.org/meta.html

Note Status History

createdAt timestampMillisOfFirstNonNMRStatus firstNonNMRStatus timestampMillisOfCurrentStatus currentStatus timestampMillisOfLatestNonNMRStatus mostRecentNonNMRStatus participantId
2023-03-20 03:37:59 UTC
(1679283479581)
1969-12-31 23:59:59 UTC
(-1)
2023-03-21 03:09:46 UTC
(1679368186219)
NEEDS_MORE_RATINGS 1969-12-31 23:59:59 UTC
(-1)

Note Ratings

rated at rated by
2023-03-20 17:34:56 -0500 Rating Details
2023-03-20 14:45:24 -0500 Rating Details
2023-03-20 12:33:05 -0500 Rating Details
2023-03-20 12:19:54 -0500 Rating Details
2023-03-20 11:55:47 -0500 Rating Details
2023-03-20 11:03:37 -0500 Rating Details
2023-03-20 10:56:50 -0500 Rating Details
2023-03-20 10:49:21 -0500 Rating Details
2023-03-20 10:49:17 -0500 Rating Details
2023-03-20 10:12:50 -0500 Rating Details
2023-03-20 09:29:02 -0500 Rating Details
2023-03-20 09:28:55 -0500 Rating Details
2023-03-20 09:20:44 -0500 Rating Details
2023-03-20 08:25:59 -0500 Rating Details
2023-03-20 08:24:34 -0500 Rating Details
2023-03-20 07:51:48 -0500 Rating Details
2023-03-20 07:50:29 -0500 Rating Details
2023-03-20 07:27:05 -0500 Rating Details
2023-03-20 06:42:20 -0500 Rating Details
2023-03-20 04:37:14 -0500 Rating Details
2023-03-20 04:29:37 -0500 Rating Details
2023-03-20 03:43:10 -0500 Rating Details
2023-03-20 02:37:27 -0500 Rating Details
2023-03-20 02:31:30 -0500 Rating Details
2023-03-20 02:22:31 -0500 Rating Details
2023-03-20 01:22:11 -0500 Rating Details
2023-03-20 01:19:21 -0500 Rating Details
2023-03-20 01:01:59 -0500 Rating Details
2023-03-19 23:49:19 -0500 Rating Details
2023-03-19 23:07:27 -0500 Rating Details
2023-03-19 22:51:32 -0500 Rating Details
2023-03-19 22:41:42 -0500 Rating Details
2023-03-21 00:17:57 -0500 Rating Details
2023-03-20 23:43:23 -0500 Rating Details
2023-03-26 08:31:42 -0500 Rating Details
2023-03-27 14:51:33 -0500 Rating Details
2023-03-27 08:20:42 -0500 Rating Details
2023-04-05 07:48:31 -0500 Rating Details
2023-03-20 10:49:21 -0500 Rating Details
2023-03-20 07:50:29 -0500 Rating Details
2023-03-20 08:24:34 -0500 Rating Details
2023-03-20 07:51:48 -0500 Rating Details
2023-03-20 08:25:59 -0500 Rating Details
2023-03-20 03:43:10 -0500 Rating Details
2023-03-20 04:37:14 -0500 Rating Details
2023-03-20 07:27:05 -0500 Rating Details
2023-03-20 23:43:23 -0500 Rating Details
2023-03-20 01:01:59 -0500 Rating Details
2023-03-20 10:49:17 -0500 Rating Details
2023-03-20 14:45:24 -0500 Rating Details
2023-03-20 01:19:21 -0500 Rating Details
2023-03-20 02:37:27 -0500 Rating Details
2023-03-20 06:42:20 -0500 Rating Details
2023-04-05 07:48:31 -0500 Rating Details
2023-03-20 09:29:02 -0500 Rating Details
2023-03-20 09:28:55 -0500 Rating Details
2023-03-20 09:20:44 -0500 Rating Details
2023-03-20 01:22:11 -0500 Rating Details
2023-03-20 11:55:47 -0500 Rating Details
2023-03-19 22:51:32 -0500 Rating Details
2023-03-26 08:31:42 -0500 Rating Details
2023-03-21 00:17:57 -0500 Rating Details
2023-03-20 11:03:37 -0500 Rating Details
2023-03-20 12:33:05 -0500 Rating Details
2023-03-27 08:20:42 -0500 Rating Details
2023-03-20 02:31:30 -0500 Rating Details
2023-03-20 10:56:50 -0500 Rating Details
2023-03-19 23:49:19 -0500 Rating Details
2023-03-20 10:12:50 -0500 Rating Details
2023-03-20 04:29:37 -0500 Rating Details
2023-03-20 12:19:54 -0500 Rating Details
2023-03-19 22:41:42 -0500 Rating Details
2023-03-19 23:07:27 -0500 Rating Details
2023-03-20 02:22:31 -0500 Rating Details
2023-03-20 17:34:56 -0500 Rating Details
2023-03-27 14:51:33 -0500 Rating Details
2023-07-11 11:12:16 -0500 Rating Details
2023-07-11 10:57:50 -0500 Rating Details
2023-07-11 10:43:40 -0500 Rating Details
2023-07-11 10:37:49 -0500 Rating Details
2023-07-11 09:55:37 -0500 Rating Details
2023-07-11 04:43:51 -0500 Rating Details
2023-07-11 04:21:08 -0500 Rating Details
2023-07-11 04:20:46 -0500 Rating Details
2023-07-11 02:51:08 -0500 Rating Details
2023-07-11 02:28:01 -0500 Rating Details